Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 99m/Tc--thiomalic acid complex: a nonstannous chelate for renal scanning

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:7292371
Thiomalic acid (monomercaptosuccinic acid) has been labeled with /sup 99m/Tc without the use of an intermediary reducing agent. Tissue distribution studies in rats following the injection of /sup 99m/Tc-tagged thiomalic acid (/sup 99m/Tc-TMA) showed 40 to 48 percent of the injected dose in the kidneys. Renal incorporation of this compound was influenced by various parameters such as pH, quantity of thiomalic acid, heating time, and the preparation-injection interval. Scintigrams of a midline kidney slice showed that the /sup 99m/Tc activity concentrated mainly in the renal cortex. As a proposed renal-imaging agent, /sup 99m/Tc-TMA compared favorably with /sup 99m/Tc-Sn-dimercaptosuccinate and /sup 99m/Tc-penicillamine regarding the percent incorporation into the kidney and was superior in this respect to /sup 99m/Tc-Sn-glucoheptonate and /sup 99m/Tc-Sn-diethylenetriamine pentaacetic acid. The /sup 99m/Tc-TMA was also shown to be highly stable through 24 hr. The reagent can be made available in kit form and is easily combined with /sup 99m/Tc in two steps. Finally, the absence of stannous ion in the /sup 99m/Tc-TMA complex should avoid the problem of interference with other procedures involving pertechnetate /sup 99m/TcO/sub 4//sup -/ as the imaging agent.
Research Organization:
Univ. of California, San Diego
OSTI ID:
7292371
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 18:4; ISSN JNMEA
Country of Publication:
United States
Language:
English